Publications by authors named "Hitoshi Kusaba"

Claim this Profile
C
Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.
Aya Takigawa, Kenji Tsuchihashi, Kenta Nio, Koji Ide, Wataru Kusano, Hitoshi Kusaba

Jpn J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study.
Kanami Furukawa, Hirofumi Ohmura, Shohei Moriyama, Koki Uehara, Mamoru Ito, Hitoshi Kusaba

Jpn J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial dynamics of CD39CD8 exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.
Kenro Tanoue, Hirofumi Ohmura, Koki Uehara, Mamoru Ito, Kyoko Yamaguchi, Hitoshi Kusaba

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy.
Shohei Moriyama, Michinari Hieda, Megumi Kisanuki, Shotaro Kawano, Taku Yokoyama, Hitoshi Kusaba

Circ J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.
Koki Uehara, Kenro Tanoue, Kyoko Yamaguchi, Hirofumi Ohmura, Mamoru Ito, Hitoshi Kusaba

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
Kenji Tsuchihashi, Mamoru Ito, Shuji Arita, Hitoshi Kusaba, Wataru Kusano

BMC Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.
Michitaka Nakano, Ryosuke Taguchi, Yoshikane Kikushige, Taichi Isobe, Kohta Miyawaki, Hitoshi Kusaba

Cancer Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807.
Takashi Ura, Shuichi Hironaka, Yasuhiro Tsubosa, Junki Mizusawa, Ken Kato, Hitoshi Kusaba

Esophagus· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
Kazuo Nishikawa, Shuichi Hironaka, Takashi Inagaki, Azusa Komori, Satoshi Otsu, Hitoshi Kusaba

Jpn J Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer.
Tomoyasu Yoshihiro, Hiroshi Ariyama, Kyoko Yamaguchi, Takashi Imajima, Satoru Yamaga, Hitoshi Kusaba

Cancer Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of renin-angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy.
Shohei Moriyama, Michinari Hieda, Megumi Kisanuki, Shotaro Kawano, Taku Yokoyama, Hitoshi Kusaba

Open Heart· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPROVE bleeding score predicts major bleeding in advanced gastrointestinal cancer patients with venous thromboembolism.
Hitoshi Kusaba, Shohei Moriyama, Michinari Hieda, Mamoru Ito, Hirofumi Ohmura

Jpn J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
Kyoko Yamaguchi, Tomoyasu Yoshihiro, Hiroshi Ariyama, Mamoru Ito, Michitaka Nakano, Hitoshi Kusaba

Gastric Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.
Yohei Chiba, Kazuki Sudo, Yuki Kojima, Hitomi Okuma, Shinji Kohsaka, Hitoshi Kusaba

BMC Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons.
Nobu Akiyama, Takuho Okamura, Minoru Yoshida, Shun-Ichi Kimura, Shingo Yano, Hitoshi Kusaba

Support Care Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation.
Shohei Moriyama, Mitsuhiro Fukata, Michinari Hieda, Taku Yokoyama, Goichi Yoshimoto, Hitoshi Kusaba

Open Heart· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous Polyposis.
Kenji Tsuchihashi, Kyoko Yamaguchi, Ryosuke Taguchi, Kenichi Kohashi, Kayo Ijichi, Hitoshi Kusaba

Case Rep Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report.
Shohei Ueno, Masato Uenomachi, Hitoshi Kusaba, Mamoru Ito, Kunihiro Suzuki

Mol Clin Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
Eijiro Shimada, Makoto Endo, Yoshihiro Matsumoto, Kenji Tsuchihashi, Mamoru Ito, Hitoshi Kusaba

J Clin Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment.
Hiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, Atsuo Takashima, Yosuke Kumekawa, Hitoshi Kusaba

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy: A case report.
Kyoko Yamaguchi, Kenji Tsuchihashi, Kunihiro Tsuji, Yosuke Kito, Kenro Tanoue, Hitoshi Kusaba

Medicine (Baltimore)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS).
Keigo Chida, Daisuke Kotani, Toshikazu Moriwaki, Shota Fukuoka, Toshiki Masuishi, Hitoshi Kusaba

Front Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer.
Ryosuke Taguchi, Kenji Tsuchihashi, Yuta Okumura, Michitaka Nakano, Tomoyasu Yoshihiro, Hitoshi Kusaba

Intern Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Kenro Tanoue, Shingo Tamura, Hitoshi Kusaba, Yudai Shinohara, Mamoru Ito

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin.
Kenji Tsuchihashi, Hitoshi Kusaba, Tomoyasu Yoshihiro, Toshifumi Fujiwara, Nokitaka Setsu

Sci Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis